XM does not provide services to residents of the United States of America.
P
P

Paycom

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. Cardinal Health, Factset, Paylocity

U.S. RESEARCH ROUNDUP-Cardinal Health, Factset, Paylocity Sept 23 (Reuters) - .Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cardinal Health, Factset and Paylocity Holding on Monday. HIGHLIGHTS * Cardinal Health Inc CAH.N : Baird raises target price to $140 from $137 * Factset FDS.N : Jefferies raises target price to $486 from $435 * Marinus Pharmaceuticals Inc MRNS.O : Oppenheimer raises to outperform from perform * Paylocity
B
P
V
A
P
C
D
L
L
U

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change Super Micro Computer Inc SMCI.OQ +6.3% United Airlines Holdings Inc UAL.OQ +5.6% Monster Beverage Corp MNST.OQ +4.8% Paycom Software Inc PAYC.N +4.8% Moderna Inc MRNA.OQ +4.5% Bottom Performers Percent Change Enphase Energy Inc ENPH.OQ
L
M
U
U
E
P

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change Super Micro Computer Inc SMCI.OQ +5.6% Moderna Inc MRNA.OQ +5.4% Paycom Software Inc PAYC.N +4.7% United Airlines Holdings Inc UAL.OQ +4.3% Boeing Co BA.N +3.7% Bottom Performers Percent Change Humana Inc HUM.N -3.5% Enphase Energy Inc
B
U
U
E
P

Law firm Orrick and plaintiffs attorney deny violating orders in data breach class action

Law firm Orrick and plaintiffs attorney deny violating orders in data breach class action By Mike Scarcella and David Thomas Aug 28 (Reuters) - Law firm Orrick, Herrington & Sutcliffe and a plaintiffs lawyer have denied violating court orders in a U.S. legal proceeding over the 2023 breach of Progress Software’s MOVEit program that affected hundreds of organizations worldwide.
P

U.S. CH Robinson Worldwide, Dayforce, Entegris

U.S. RESEARCH ROUNDUP-CH Robinson Worldwide, Dayforce, Entegris Aug 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CH Robinson Worldwide, Dayforce and Entegris, on Thursday. HIGHLIGHTS * CH Robinson Worldwide Inc CHRW.O : JP Morgan raises to overweight from neutral * Dayforce Inc DAY.N : Piper Sandler raises to overweight from neutral * Entegris Inc ENTG.O : Seaport Research Partners raises to buy from neutral * M
B
C
D
E
M
Q
S
V
A
C
D
E
L
T
P
W
A
B
C

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.